dc.contributor.author
Sabat, Robert
dc.contributor.author
Wolk, Kerstin
dc.date.accessioned
2018-06-08T02:58:11Z
dc.date.available
2016-01-18T10:41:46.194Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/14225
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-18421
dc.description.abstract
Inflammatory processes and metabolic alterations are supposed to substantially
interact. Recently, cumulating reports describe a profound role of
interleukin(IL)-22 in this relationship. IL-22 is a particular kind of immune
mediator that is produced by certain lymphocyte populations and regulates the
function of several tissue cells but not immune cells. So far, IL-22 was known
to plays a fundamental role in the elimination of bacterial infections at
border surfaces of the body and to protect tissues from damage. This research
highlight article arranges the facts regarding the effects of IL-22 in the
context of adiposity and metabolic alterations and postulates a new function
of the immune system.
en
dc.rights.uri
http://creativecommons.org/licenses/by/4.0/
dc.subject
Metabolic alterations
dc.subject
Diabetes mellitus
dc.subject
Arteriosclerosis
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit
dc.title
Deciphering the role of interleukin-22 in metabolic alterations
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation
Cell & Bioscience. - 5 (2015), Artikel Nr. 68
dcterms.bibliographicCitation.doi
10.1186/s13578-015-0060-8
dcterms.bibliographicCitation.url
http://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-015-0060-8
refubium.affiliation
Charité - Universitätsmedizin Berlin
de
refubium.mycore.fudocsId
FUDOCS_document_000000023733
refubium.note.author
Der Artikel wurde in einer Open-Access-Zeitschrift publiziert.
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000005851
dcterms.accessRights.openaire
open access
